|
1
|
Charlson FJ, Ferrari AJ, Santomauro DF,
Diminic S, Stockings E, Scott JG, McGrath JJ and Whiteford HA:
Global epidemiology and burden of schizophrenia: Findings from the
global burden of disease study 2016. Schizophr Bull. 44:1195–1203.
2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hilker R, Helenius D, Fagerlund B, Skytthe
A, Christensen K, Werge TM, Nordentoft M and Glenthøj B:
Heritability of schizophrenia and schizophrenia spectrum based on
the nationwide danish twin register. Biol Psychiatry. 83:492–498.
2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lesh TA, Niendam TA, Minzenberg MJ and
Carter CS: Cognitive control deficits in schizophrenia: Mechanisms
and meaning. Neuropsychopharmacology. 36:316–338. 2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mighdoll MI, Tao R, Kleinman JE and Hyde
TM: Myelin, myelin-related disorders, and psychosis. Schizophr Res.
161:85–93. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Gouvêa-Junqueira D, Falvella ACB, Antunes
ASLM, Seabra G, Brandão-Teles C, Martins-de-Souza D and Crunfli F:
Novel treatment strategies targeting myelin and oligodendrocyte
dysfunction in schizophrenia. Front Psychiatry.
11(379)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Raabe FJ, Galinski S, Papiol S, Falkai PG,
Schmitt A and Rossner MJ: Studying and modulating
schizophrenia-associated dysfunctions of oligodendrocytes with
patient-specific cell systems. NPJ Schizophr. 4(23)2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
He J, Zu Q, Wen C, Liu Q, You P, Li X and
Wang W: Quetiapine attenuates schizophrenia-like behaviors and
demyelination in a MK-801-induced mouse model of schizophrenia.
Front Psychiatry. 11(843)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Falkai P, Malchow B, Wetzestein K,
Nowastowski V, Bernstein HG, Steiner J, Schneider-Axmann T, Kraus
T, Hasan A, Bogerts B, et al: Decreased oligodendrocyte and neuron
number in anterior hippocampal areas and the entire hippocampus in
schizophrenia: A stereological postmortem study. Schizophr Bull. 42
(Suppl 1):S4–S12. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Falkai P, Steiner J, Malchow B, Shariati
J, Knaus A, Bernstein HG, Schneider-Axmann T, Kraus T, Hasan A,
Bogerts B and Schmitt A: Oligodendrocyte and interneuron density in
hippocampal subfields in schizophrenia and association of
oligodendrocyte number with cognitive deficits. Front Cell
Neurosci. 10(78)2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Vikhreva OV, Rakhmanova VI, Orlovskaya DD
and Uranova NA: Ultrastructural alterations of oligodendrocytes in
prefrontal white matter in schizophrenia: A post-mortem
morphometric study. Schizophr Res. 177:28–36. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Choudhury H, Chellappan DK, Sengupta P,
Pandey M and Gorain B: Adenosine receptors in modulation of central
nervous system disorders. Curr Pharm Des. 25:2808–2827.
2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Pierce KD, Furlong TJ, Selbie LA and Shine
J: Molecular cloning and expression of an adenosine A2b receptor
from human brain. Biochem Biophys Res Commun. 187:86–93.
1992.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Dixon AK, Gubitz AK, Sirinathsinghji DJ,
Richardson PJ and Freeman TC: Tissue distribution of adenosine
receptor mRNAs in the rat. Br J Pharmacol. 118:1461–1468.
1996.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Liu YJ, Chen J, Li X, Zhou X, Hu YM, Chu
SF, Peng Y and Chen NH: Research progress on adenosine in central
nervous system diseases. CNS Neurosci Ther. 25:899–910.
2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Beukers MW, den Dulk H, van Tilburg EW,
Brouwer J and Ijzerman AP: Why are A(2B) receptors low-affinity
adenosine receptors? Mutation of Asn273 to Tyr increases affinity
of human A(2B) receptor for 2-(1-Hexynyl)adenosine. Mol Pharmacol.
58:1349–1356. 2000.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Haskó G, Csóka B, Németh ZH, Vizi ES and
Pacher P: A(2B) adenosine receptors in immunity and inflammation.
Trends Immunol. 30:263–270. 2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kong T, Westerman KA, Faigle M, Eltzschig
HK and Colgan SP: HIF-dependent induction of adenosine A2B receptor
in hypoxia. FASEB J. 20:2242–2250. 2006.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Manalo JM, Liu H, Ding D, Hicks J, Sun H,
Salvi R, Kellems RE, Pereira FA and Xia Y: Adenosine A2B receptor:
A pathogenic factor and a therapeutic target for sensorineural
hearing loss. FASEB J. 34:15771–15787. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Doyle C, Cristofaro V, Sack BS, Lukianov
SN, Schäfer M, Chung YG, Sullivan MP and Adam RM: Inosine
attenuates spontaneous activity in the rat neurogenic bladder
through an A2B pathway. Sci Rep. 7(44416)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Gile J, Oyama Y, Shuff S and Eckle T: A
role for the adenosine ADORA2B receptor in midazolam induced
cognitive dysfunction. Curr Pharm Des. 26:4330–4337.
2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang J, Wang D, Zheng X, Li Y, Li Y, Ma T,
Li J, Sun J, Wang Y and Ma Q: A2B adenosine receptor
inhibition ameliorates hypoxic-ischemic injury in neonatal mice via
PKC/Erk/Creb/HIF-1α signaling pathway. Brain Res.
1782(147837)2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Winship IR, Dursun SM, Baker GB, Balista
PA, Kandratavicius L, Maia-de-Oliveira JP, Hallak J and Howland JG:
An overview of animal models related to schizophrenia. Can J
Psychiatry. 64:5–17. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Adell A: Brain NMDA receptors in
schizophrenia and depression. Biomolecules. 10(947)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Catts VS, Lai YL, Weickert CS, Weickert TW
and Catts SV: A quantitative review of the postmortem evidence for
decreased cortical N-methyl-D-aspartate receptor expression levels
in schizophrenia: How can we link molecular abnormalities to
mismatch negativity deficits? Biol Psychol. 116:57–67.
2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Eyjolfsson EM, Brenner E, Kondziella D and
Sonnewald U: Repeated injection of MK801: An animal model of
schizophrenia? Neurochem Int. 48:541–546. 2006.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ding J, Zhou HH, Ma QR, He ZY, Ma JB, Liu
YM, Zhang YW, He YQ and Liu J: Expression of NR1 and apoptosis
levels in the hippocampal cells of mice treated with MK-801. Mol
Med Rep. 16:8359–8364. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wen J, Wang B, Du C, Xu G, Zhang Z, Li Y
and Zhang N: A2B adenosine receptor agonist improves erectile
function in diabetic rats. Tohoku J Exp Med. 237:141–148.
2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tian Y, Piras BA, Kron IL, French BA and
Yang Z: Adenosine 2B receptor activation reduces myocardial
reperfusion injury by promoting anti-inflammatory macrophages
differentiation via PI3K/Akt pathway. Oxid Med Cell Longev.
2015(585297)2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kaji W, Tanaka S, Tsukimoto M and Kojima
S: Adenosine A(2B) receptor antagonist PSB603 suppresses tumor
growth and metastasis by inhibiting induction of regulatory T
cells. J Toxicol Sci. 39:191–198. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Shao Y, Ding J, He QX, Ma QR, Liu Q, Zhang
C, Lv HW and Liu J: Effect of Sox10 on remyelination of the
hippocampus in cuprizone-induced demyelinated mice. Brain Behav.
10(e01623)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kuhn S, Gritti L, Crooks D and Dombrowski
Y: Oligodendrocytes in development, myelin generation and beyond.
Cells. 8(1424)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Cherchi F, Pugliese AM and Coppi E:
Oligodendrocyte precursor cell maturation: Role of adenosine
receptors. Neural Regen Res. 16:1686–1692. 2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yazdankhah M, Ghosh S, Shang P, Stepicheva
N, Hose S, Liu H, Chamling X, Tian S, Sullivan MLG, Calderon MJ, et
al: BNIP3L-mediated mitophagy is required for mitochondrial
remodeling during the differentiation of optic nerve
oligodendrocytes. Autophagy. 17:3140–3159. 2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Coyle JT: The glutamatergic dysfunction
hypothesis for schizophrenia. Harv Rev Psychiatry. 3:241–253.
1996.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Deakin JF, Slater P, Simpson MD, Gilchrist
AC, Skan WJ, Royston MC, Reynolds GP and Cross AJ: Frontal cortical
and left temporal glutamatergic dysfunction in schizophrenia. J
Neurochem. 52:1781–1786. 1989.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Mohn AR, Gainetdinov RR, Caron MG and
Koller BH: Mice with reduced NMDA receptor expression display
behaviors related to schizophrenia. Cell. 98:427–436.
1999.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Sheri AT and Stephen RS: A review of NMDA
receptors and the phencyclidine model of schizophrenia.
Pharmacotherapy. 16:82–93. 1996.PubMed/NCBI
|
|
38
|
Park SJ, Lee Y, Oh HK, Lee HE, Lee Y, Ko
SY, Kim B, Cheong JH, Shin CY and Ryu JH: Oleanolic acid attenuates
MK-801-induced schizophrenia-like behaviors in mice.
Neuropharmacology. 86:49–56. 2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Missault S, Van den Eynde K, Vanden Berghe
W, Fransen E, Weeren A, Timmermans JP, Kumar-Singh S and
Dedeurwaerdere S: The risk for behavioural deficits is determined
by the maternal immune response to prenatal immune challenge in a
neurodevelopmental model. Brain Behav Immun. 42:138–146.
2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Kiljan S, Prins M, Baselmans BM, Bol JGJM,
Schenk GJ and van Dam AM: Enhanced GABAergic immunoreactivity in
hippocampal neurons and astroglia of multiple sclerosis patients. J
Neuropathol Exp Neurol. 78:480–491. 2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Deoni S, Dean D III, Joelson S, O'Regan J
and Schneider N: Early nutrition influences developmental
myelination and cognition in infants and young children.
Neuroimage. 178:649–659. 2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Yang Y, Zhang Y, Luo F and Li B: Chronic
stress regulates NG2+ cell maturation and myelination in the
prefrontal cortex through induction of death receptor 6. Exp
Neurol. 277:202–214. 2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Takahashi N, Sakurai T, Davis KL and
Buxbaum JD: Linking oligodendrocyte and myelin dysfunction to
neurocircuitry abnormalities in schizophrenia. Prog Neurobiol.
93:13–24. 2011.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Xiu Y, Kong XR, Zhang L, Qiu X, Gao Y,
Huang CX, Chao FL, Wang SR and Tang Y: The myelinated fiber loss in
the corpus callosum of mouse model of schizophrenia induced by
MK-801. J Psychiatr Res. 63:132–140. 2015.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Sampaio-Baptista C and Johansen-Berg H:
White matter plasticity in the adult brain. Neuron. 96:1239–1251.
2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Valny M, Honsa P, Kriska J and Anderova M:
Multipotency and therapeutic potential of NG2 cells. Biochem
Pharmacol. 141:42–55. 2017.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Coleman LG Jr, Jarskog LF, Moy SS and
Crews FT: Deficits in adult prefrontal cortex neurons and behavior
following early post-natal NMDA antagonist treatment. Pharmacol
Biochem Behav. 93:322–330. 2009.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Kawabe K and Miyamoto E: Effects of
neonatal repeated MK-801 treatment on delayed
nonmatching-to-position responses in rats. Neuroreport. 19:969–973.
2008.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Guest PC, Iwata K, Kato TA, Steiner J,
Schmitt A, Turck CW and Martins-de-Souza D: MK-801 treatment
affects glycolysis in oligodendrocytes more than in astrocytes and
neuronal cells: Insights for schizophrenia. Front Cell Neurosci.
9(180)2015.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Fratangeli A, Parmigiani E, Fumagalli M,
Lecca D, Benfante R, Passafaro M, Buffo A, Abbracchio MP and Rosa
P: The regulated expression, intracellular trafficking, and
membrane recycling of the P2Y-like receptor GPR17 in Oli-neu
oligodendroglial cells. J Biol Chem. 288:5241–5256. 2013.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Wang J, He X, Meng H, Li Y, Dmitriev P,
Tian F, Page JC, Lu QR and He Z: Robust myelination of regenerated
axons induced by combined manipulations of GPR17 and microglia.
Neuron. 108:876–886.e4. 2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Fumagalli M, Daniele S, Lecca D, Lee PR,
Parravicini C, Fields RD, Rosa P, Antonucci F, Verderio C,
Trincavelli ML, et al: Phenotypic changes, signaling pathway, and
functional correlates of GPR17-expressing neural precursor cells
during oligodendrocyte differentiation. J Biol Chem.
286:10593–10604. 2011.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Merten N, Fischer J, Simon K, Zhang L,
Schröder R, Peters L, Letombe AG, Hennen S, Schrage R, Bödefeld T,
et al: Repurposing HAMI3379 to block GPR17 and promote rodent and
human oligodendrocyte differentiation. Cell Chem Biol.
25:775–786.e5. 2018.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Ou Z, Sun Y, Lin L, You N, Liu X, Li H, Ma
Y, Cao L, Han Y, Liu M, et al: Olig2-targeted G-protein-coupled
receptor Gpr17 regulates oligodendrocyte survival in response to
lysolecithin-induced demyelination. J Neurosci. 36:10560–10573.
2016.PubMed/NCBI View Article : Google Scholar
|
